SEC Form 4 · accession 0001209191-17-066071
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Isaacs
Officer — President and CEO · Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 15, 2017 · 8:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 15, 2017 | G | 61,725 | $0.00 | D | 8,932 | I | By Family Trust |
| Common StockF1 | Dec 15, 2017 | G | 12,375 | $0.00 | D | 205,746 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee, were given as a bona fide gift to the University of California, Berkeley.
- F2The shares are owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee.